| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11275298P | 1998-12-17 | 1998-12-17 | |
| PCT/US1999/029873WO2000036092A2 (en) | 1998-12-17 | 1999-12-16 | METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| Publication Number | Publication Date |
|---|---|
| IL143670A0true IL143670A0 (en) | 2002-04-21 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14367099AIL143670A0 (en) | 1998-12-17 | 1999-12-16 | Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same |
| IL205698AIL205698A (en) | 1998-12-17 | 2010-05-11 | Methods for increasing expression of active tumor necrosis factor (tnf) receptor family member - ig fc fusion proteins and minimizing expression of inactive tnf receptor family member ig fc fusion proteins |
| IL229738AIL229738A0 (en) | 1998-12-17 | 2013-12-01 | Methods and compositions for increasing expression of active tumor necrosis factor (tnf)receptor family member-lg fc fusion proteins |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL205698AIL205698A (en) | 1998-12-17 | 2010-05-11 | Methods for increasing expression of active tumor necrosis factor (tnf) receptor family member - ig fc fusion proteins and minimizing expression of inactive tnf receptor family member ig fc fusion proteins |
| IL229738AIL229738A0 (en) | 1998-12-17 | 2013-12-01 | Methods and compositions for increasing expression of active tumor necrosis factor (tnf)receptor family member-lg fc fusion proteins |
| Country | Link |
|---|---|
| US (3) | US7585946B2 (en) |
| EP (3) | EP2374872B2 (en) |
| JP (4) | JP4878676B2 (en) |
| KR (3) | KR20020013482A (en) |
| CN (2) | CN100387708C (en) |
| AT (1) | ATE536372T1 (en) |
| AU (2) | AU777232B2 (en) |
| BR (1) | BR9916325B1 (en) |
| CA (1) | CA2354539A1 (en) |
| CY (1) | CY1117003T1 (en) |
| CZ (1) | CZ20012156A3 (en) |
| DK (2) | DK2374872T4 (en) |
| EA (1) | EA005270B1 (en) |
| EE (1) | EE200100324A (en) |
| ES (1) | ES2554482T5 (en) |
| HK (1) | HK1223398A1 (en) |
| HU (1) | HUP0200064A2 (en) |
| IL (3) | IL143670A0 (en) |
| IS (1) | IS5959A (en) |
| NO (1) | NO20012991L (en) |
| NZ (3) | NZ529276A (en) |
| PT (1) | PT2374872E (en) |
| SG (1) | SG123531A1 (en) |
| SI (1) | SI2374872T2 (en) |
| SK (1) | SK8552001A3 (en) |
| TR (2) | TR200504220T2 (en) |
| WO (1) | WO2000036092A2 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5925351A (en)* | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| US7060667B1 (en) | 1998-01-30 | 2006-06-13 | Biogen Idec Ma, Inc. | Treatment of follicular lymphomas using inhibitors of the LT pathway |
| TR200100974T2 (en)* | 1998-10-09 | 2001-11-21 | Biogen, Inc. | Systematic shock and respiratory distress caused by virus rejection by blocking the lymphotoxin beta pathway |
| AU2001257445B2 (en) | 2000-04-28 | 2006-11-02 | Planet Biotechnology, Inc. | Immunoadhesin for the prevention of rhinovirus infection |
| US20020168367A1 (en)* | 2000-04-28 | 2002-11-14 | Planet Biotechnology Incorporated | Novel immunoadhesins for treating and preventing viral and bacterial diseases |
| US20090137416A1 (en) | 2001-01-16 | 2009-05-28 | Regeneron Pharmaceuticals, Inc. | Isolating Cells Expressing Secreted Proteins |
| CA2434802C (en)* | 2001-01-16 | 2013-05-28 | Regeneron Pharmaceuticals, Inc. | Isolating cells expressing secreted proteins |
| JP2006515750A (en)* | 2002-12-20 | 2006-06-08 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Multivalent lymphotoxin β receptor agonist and treatment using the same |
| MXPA05006523A (en) | 2002-12-23 | 2005-08-26 | Squibb Bristol Myers Co | Mammalian cell culture processes for protein production. |
| TWI328614B (en) | 2002-12-23 | 2010-08-11 | Bristol Myers Squibb Co | Product quality enhancement in mammalian cell culture processes for protein production |
| WO2005024012A1 (en)* | 2003-09-11 | 2005-03-17 | Novozymes A/S | Increased expression of a modified polypeptide |
| US20070099266A1 (en)* | 2003-12-23 | 2007-05-03 | Applied Research Systems Ars Holding N.V. | Process for the production of tumor necrosis factor-binding proteins |
| US20110038854A1 (en)* | 2006-03-30 | 2011-02-17 | University Of Medicine And Dentistry Of New Jersey | Strategy for homo- or hetero-dimerization of various proteins in solution and in cell |
| EP2084188A2 (en)* | 2006-10-12 | 2009-08-05 | Genentech, Inc. | Antibodies to lymphotoxin-alpha |
| EP2311481A3 (en)* | 2006-10-20 | 2013-10-16 | Biogen Idec MA Inc. | Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor |
| US8338376B2 (en) | 2006-10-20 | 2012-12-25 | Biogen Idec Ma Inc. | Compositions comprising variant LT-B-R-IG fusion proteins |
| CA2680792A1 (en)* | 2007-03-15 | 2008-09-18 | Biogen Idec Ma Inc. | Treatment of autoimmune disorders |
| TW200902708A (en) | 2007-04-23 | 2009-01-16 | Wyeth Corp | Methods of protein production using anti-senescence compounds |
| BRPI0908270A2 (en)* | 2008-02-29 | 2019-09-10 | Biogen Idec Inc | purified immunoglobulin fusion proteins and method for their purification |
| US9540426B2 (en) | 2009-10-06 | 2017-01-10 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
| LT2563906T (en) | 2010-04-26 | 2018-02-26 | Novartis Ag | Process for cultivation of cho cells |
| WO2012176158A1 (en)* | 2011-06-24 | 2012-12-27 | Dr. Reddy's Laboratories Limited | Purification of chimeric protein |
| EP2753634B1 (en) | 2011-08-17 | 2017-11-01 | Ares Trading S.A. | Method for preparing active form of tnfr-fc fusion protein |
| ES2633960T3 (en) | 2012-10-15 | 2017-09-26 | Bristol-Myers Squibb Company | Processes of mammalian cell culture for protein production |
| TWI864338B (en) | 2012-11-14 | 2024-12-01 | 美商再生元醫藥公司 | Recombinant cell surface capture proteins |
| IL297395B2 (en) | 2015-06-30 | 2024-01-01 | Pfizer | Btla fusion protein agonists and uses thereof |
| KR101936049B1 (en) | 2015-10-15 | 2019-01-08 | (주)알테오젠 | Method for manufacturing fusion proteins with IgG Fc domain |
| CN105400721A (en)* | 2015-12-11 | 2016-03-16 | 湖南农业大学 | Method for rapid screening of Bacillus spp with antibacterial activity |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2906096A (en) | 1953-12-14 | 1959-09-29 | Pacific Ind Mfg Co | Precision control system for press brakes or the like |
| EP0480923B1 (en) | 1989-07-04 | 1993-09-29 | Novo Nordisk A/S | Method of producing proteins with fviii activity and/or fviii derivatives |
| US5605690A (en)* | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| WO1992000329A1 (en) | 1990-06-27 | 1992-01-09 | Biogen, Inc. | Surface complexed lymphotoxin |
| US7030080B2 (en) | 1990-06-27 | 2006-04-18 | Biogen, Inc. | Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| US5795964A (en) | 1990-06-27 | 1998-08-18 | Biogen, Inc. | Lymphotoxin-beta and lymphotoxin-beta complexes |
| WO1992020791A1 (en) | 1990-07-10 | 1992-11-26 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
| NZ260103A (en)* | 1990-11-30 | 1996-10-28 | Bio Technology General Corp | Somatotropin with alterations in the alpha-helix-1 region |
| US5656272A (en) | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| IE922437A1 (en) | 1991-07-25 | 1993-01-27 | Idec Pharma Corp | Recombinant antibodies for human therapy |
| US5447851B1 (en)* | 1992-04-02 | 1999-07-06 | Univ Texas System Board Of | Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells |
| US5643570A (en)* | 1992-05-19 | 1997-07-01 | Xoma Corporation | BPI-immunoglobulin fusion proteins |
| WO1994006476A1 (en)* | 1992-09-15 | 1994-03-31 | Immunex Corporation | Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| WO1994006478A1 (en) | 1992-09-22 | 1994-03-31 | Medin Corporation | A system for securing medical tools for sterilization |
| AU690528B2 (en) | 1992-12-04 | 1998-04-30 | Medical Research Council | Multivalent and multispecific binding proteins, their manufacture and use |
| US5691196A (en)* | 1992-12-31 | 1997-11-25 | American Cyanamid Company | Recombinant nucleic acid containing a response element |
| US5429746A (en)* | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| US5856179A (en) | 1994-03-10 | 1999-01-05 | Genentech, Inc. | Polypeptide production in animal cell culture |
| US5726039A (en) | 1994-07-21 | 1998-03-10 | Yissum Research Development Co. Of The Hebrew University Of Jerusalem | Vectors and transformed host cells for recombinant protein production at reduced temperatures |
| US5541087A (en) | 1994-09-14 | 1996-07-30 | Fuji Immunopharmaceuticals Corporation | Expression and export technology of proteins as immunofusins |
| US6312691B1 (en) | 1996-01-26 | 2001-11-06 | Jeffrey L. Browning | Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents |
| US5705364A (en)* | 1995-06-06 | 1998-01-06 | Genentech, Inc. | Mammalian cell culture process |
| US5721121A (en)* | 1995-06-06 | 1998-02-24 | Genentech, Inc. | Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein |
| US5925351A (en) | 1995-07-21 | 1999-07-20 | Biogen, Inc. | Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| US6291207B1 (en)* | 1995-07-28 | 2001-09-18 | Northwestern University | Herpes virus entry receptor protein |
| JP4306813B2 (en) | 1995-09-19 | 2009-08-05 | アスビオファーマ株式会社 | New method for culturing animal cells |
| EP0910413A2 (en)* | 1996-05-08 | 1999-04-28 | F. Hoffmann-La Roche Ag | TREATMENT OF ASTHMA WITH TNFR-Ig |
| US6040560A (en)* | 1996-10-22 | 2000-03-21 | Philip Morris Incorporated | Power controller and method of operating an electrical smoking system |
| US7255854B1 (en) | 1996-10-25 | 2007-08-14 | Biogen, Inc. | Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases |
| CN100382844C (en) | 1996-10-25 | 2008-04-23 | 拜奥根Idec马萨诸塞公司 | Soluble beta-lymphotoxin receptor and anti-lymphotoxin receptor antibodies and uses of anti-lymphotoxin ligand antibodies |
| WO1998018824A1 (en)* | 1996-10-30 | 1998-05-07 | Human Genome Sciences, Inc. | Human tumor necrosis factor receptor-like 2 |
| CA2272822A1 (en)* | 1996-12-12 | 1998-06-18 | Genentech, Inc. | Hvem polypeptides and uses thereof |
| US6221608B1 (en)* | 1997-01-22 | 2001-04-24 | Ortho Pharmaceutical Corporation | Methods for identifying erythropoietin receptor binding protein |
| US7060667B1 (en) | 1998-01-30 | 2006-06-13 | Biogen Idec Ma, Inc. | Treatment of follicular lymphomas using inhibitors of the LT pathway |
| AU763513B2 (en)* | 1998-04-16 | 2003-07-24 | Genentech Inc. | Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
| DE69929198T2 (en) | 1998-05-29 | 2006-08-10 | Genentech, Inc., South San Francisco | CELL CULTURE PROCESS FOR THE PRODUCTION OF GLYCOPROTEINS |
| TR200100974T2 (en)* | 1998-10-09 | 2001-11-21 | Biogen, Inc. | Systematic shock and respiratory distress caused by virus rejection by blocking the lymphotoxin beta pathway |
| US7294481B1 (en) | 1999-01-05 | 2007-11-13 | Immunex Corporation | Method for producing recombinant proteins |
| US9086881B2 (en) | 2012-06-29 | 2015-07-21 | Intel Corporation | Mechanism for facilitating write tracking for following data eye movements across changing thermal conditions in memory systems |
| Publication | Publication Date | Title |
|---|---|---|
| IL143670A0 (en) | Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same | |
| IL185142A0 (en) | Lentiviral packaging constructs | |
| IL130190A0 (en) | Methods and compositions for polypeptide engineering | |
| IL132067A0 (en) | Apo-2 receptor | |
| BG105028A (en) | Bridged indenopyrrolocarbazoles | |
| TR200000152T2 (en) | New compounds. | |
| NZ330837A (en) | Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon | |
| NO992916L (en) | Phosphodiesterase 8A | |
| MXPA01003868A (en) | Apomixis conferred by expression of serk interacting proteins. | |
| EP0990703A4 (en) | Novel polypeptide, dna encoding the same and use thereof | |
| IL128500A (en) | SUBSTITUTED 1,2,3,4-TETRAHYDRO-2-DIBENZOFURANAMINES AND 2-AMINOCYCLOHEPTA[b] BENZOFURANS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
| BR9713176A (en) | Amorphous benzothiophenes, methods of preparation and methods of use | |
| EE04944B1 (en) | Bacterial plasmids for use as expression vectors or for microbiological analysis | |
| YU26001A (en) | Ureidopiperidine derivatives as selective human nk3 receptor antagonists | |
| EP0778833A4 (en) | Endothelin receptor antagonists | |
| ID27656A (en) | AZABISIKLOHEPTANA N-SUBSTITUTIONAL DERIVES, THE PRODUCTION AND USE OF IT | |
| IL148234A0 (en) | Composition for ivf | |
| ES2051953T3 (en) | ISOMEROUS DERIVATIVES OF TRIMETILBICICLO (4,3,0) NONANO. | |
| AU1801699A (en) | Creation of heteroimmunity amongst ctx$g(f): methods and compounds for the construction of improved (v. cholerae) vaccines | |
| ID27964A (en) | TURUNA-AZABISIKLOHEPTANA N-SUBSTITUTED, MAKING AND USING IT | |
| MY127539A (en) | Bridged indenopyrrolocarbazoles | |
| MX9804706A (en) | Fused isoindolones as inhibitors of protein kinase c. | |
| UA30553C2 (en) | Vodka SPECIAL "UNION" | |
| ECSP961901A (en) | IMIDAZOLIDIN COMPOUNDS 2,4- DIONA SUBSTITUTED |